{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T04:02:04Z","timestamp":1792555324615,"version":"4.5.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.nbd.2022.105783","type":"journal-article","created":{"date-parts":[[2022,6,5]],"date-time":"2022-06-05T17:09:34Z","timestamp":1654448974000},"page":"105783","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Systemic perturbations of the kynurenine pathway precede progression to dementia independently of amyloid-\u03b2"],"prefix":"10.1016","volume":"171","author":[{"given":"Marcela","family":"Cespedes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly R.","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Maruff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Rembach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Fowler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett","family":"Trounson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly K.","family":"Pertile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca L.","family":"Rumble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie R.","family":"Rainey-Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher C.","family":"Rowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor L.","family":"Villemagne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierrick","family":"Bourgeat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chai K.","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pratishtha","family":"Chatterjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph N.","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arne","family":"Ittner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin L.","family":"Masters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James D.","family":"Doecke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles J.","family":"Guillemin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B.","family":"Lovejoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2022.105783_bb0005","doi-asserted-by":"crossref","first-page":"69347","DOI":"10.18632\/oncotarget.12469","article-title":"Neuroprotective effects of CD4+CD25+Foxp3+ regulatory T cells in a 3xTg-AD Alzheimer\u2019s disease model","volume":"7","author":"Baek","year":"2016","journal-title":"Oncotarget."},{"key":"10.1016\/j.nbd.2022.105783_bb0010","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1007\/s00125-021-05521-4","article-title":"Associations between plasma kynurenines and cognitive function in individuals with normal glucose metabolism, prediabetes and type 2 diabetes: the Maastricht study","volume":"64","author":"Bakker","year":"2021","journal-title":"Diabetologia."},{"key":"10.1016\/j.nbd.2022.105783_bb0015","doi-asserted-by":"crossref","first-page":"7967","DOI":"10.1038\/ncomms8967","article-title":"Breaking immune tolerance by targeting Foxp3(+) regulatory T cells mitigates Alzheimer\u2019s disease pathology","volume":"6","author":"Baruch","year":"2015","journal-title":"Nat. Comm."},{"key":"10.1016\/j.nbd.2022.105783_bb0020","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.neuroimage.2018.08.044","article-title":"Implementing the centiloid transformation for 11C-PiB and \u03b2-amyloid 18F-PET tracers using CapAIBL","volume":"183","author":"Bourgeat","year":"2018","journal-title":"NeuroImage"},{"key":"10.1016\/j.nbd.2022.105783_bb0025","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s12640-009-9051-z","article-title":"Mechanism for quinolinic acid cytotoxicity in human astrocytes and neurons","volume":"16","author":"Braidy","year":"2009","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.nbd.2022.105783_bb0030","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1007\/s12640-019-9997-4","article-title":"Kynurenine 3-monooxygenase activity in human primary neurons and effect on cellular bioenergetics identifies new neurotoxic mechanisms","volume":"35","author":"Castellano-Gonzalez","year":"2019","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.nbd.2022.105783_bb0035","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1186\/s12974-019-1567-4","article-title":"Plasma neurofilament light chain and amyloid-\u03b2 are associated with the kynurenine pathway metabolites in preclinical Alzheimer\u2019s disease","volume":"16","author":"Chatterjee","year":"2019","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.nbd.2022.105783_bb0040","first-page":"51","article-title":"On the biological importance of the 3-hydroxyanthranilic acid: anthranilic acid ratio","volume":"3","author":"Darlington","year":"2010","journal-title":"Int. J. Tryp. Res."},{"key":"10.1016\/j.nbd.2022.105783_bb0045","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/s41435-020-00113-5","article-title":"Tau at the interface between neurodegeneration and neuroinflammation","volume":"21","author":"Didonna","year":"2020","journal-title":"Genes Immun."},{"key":"10.1016\/j.nbd.2022.105783_bb0050","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1001\/jamaneurol.2014.803","article-title":"The preclinical Alzheimer cognitive composite: measuring amyloid-related decline","volume":"71","author":"Donohue","year":"2014","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.nbd.2022.105783_bb0055","first-page":"1","article-title":"The associations between cognitive prognosis and kynurenines are modified by the apolipoprotein \u03b54 allele variant in patients with dementia","volume":"12","author":"Ervik","year":"2019","journal-title":"Int. J. Tryp. Res."},{"key":"10.1016\/j.nbd.2022.105783_bb0060","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.bbi.2016.02.009","article-title":"T-cell brain infiltration and immature antigen-presenting cells in transgenic models of Alzheimer\u2019s disease-like cerebral amyloidosis","volume":"54","author":"Ferretti","year":"2016","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.nbd.2022.105783_bb0065","doi-asserted-by":"crossref","first-page":"443","DOI":"10.3233\/ADR-210005","article-title":"Fifteen years of the Australian imaging, biomarkers and lifestyle (AIBL) study: Progress and observations from 2,359 older adults spanning the spectrum from cognitive normality to Alzheimer\u2019s disease","volume":"5","author":"Fowler","year":"2021","journal-title":"J. Alzheimer\u2019s Dis. Reports."},{"key":"10.1016\/j.nbd.2022.105783_bb0070","doi-asserted-by":"crossref","first-page":"495","DOI":"10.3233\/JAD-170485","article-title":"Kynurenine pathway metabolites in Alzheimer\u2019s disease","volume":"60","author":"Giil","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.nbd.2022.105783_bb0075","doi-asserted-by":"crossref","first-page":"7266","DOI":"10.1021\/bi992997s","article-title":"3-Hydroxykynurenine and 3-hydroxyanthranilic acid generate hydrogen peroxide and promote alpha-crystallin cross-linking by metal ion reduction","volume":"39","author":"Goldstein","year":"2000","journal-title":"Biochemistry."},{"key":"10.1016\/j.nbd.2022.105783_bb0080","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1111\/j.1742-4658.2012.08485.x","article-title":"Quinolinic acid, the inescapable neurotoxin","volume":"279","author":"Guillemin","year":"2012","journal-title":"FEBS J."},{"key":"10.1016\/j.nbd.2022.105783_bb0085","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1365-2990.2005.00655.x","article-title":"Indoleamine 2,3 dioxygenase and quinolinic acid immunoreactivity in Alzheimer\u2019s disease hippocampus","volume":"31","author":"Guillemin","year":"2005","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.nbd.2022.105783_bb0090","doi-asserted-by":"crossref","first-page":"12884","DOI":"10.1523\/JNEUROSCI.4101-07.2007","article-title":"Characterization of the kynurenine pathway in human neurons","volume":"27","author":"Guillemin","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2022.105783_bb0095","doi-asserted-by":"crossref","first-page":"204","DOI":"10.2478\/v10039-010-0023-6","article-title":"Kynurenine and its metabolites in Alzheimer's disease patients","volume":"55","author":"Gulaj","year":"2010","journal-title":"Adv. Med. Sci."},{"key":"10.1016\/j.nbd.2022.105783_bb0100","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.neuint.2006.08.012","article-title":"Decreased serum and red blood cell kynurenic acid levels in Alzheimer's disease","volume":"50","author":"Hartai","year":"2007","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.nbd.2022.105783_bb0105","doi-asserted-by":"crossref","first-page":"18619","DOI":"10.1073\/pnas.0709261104","article-title":"3-Hydroxyanthranilic acid inhibits PDK1 activation and suppresses experimental asthma by inducing T cell apoptosis","volume":"104","author":"Hayashi","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2022.105783_bb0110","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","article-title":"Neuroinflammation in Alzheimer\u2019s disease","volume":"14","author":"Heneka","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2022.105783_bb0115","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.2174\/0929867324666170502123114","article-title":"Major developments in the design of inhibitors along the kynurenine pathway","volume":"24","author":"Jacobs","year":"2017","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.nbd.2022.105783_bb0120","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.neurobiolaging.2019.03.015","article-title":"Correlation between plasma and CSF concentrations of kynurenine pathway metabolites in Alzheimer\u2019s disease and relationship to amyloid-\u03b2 and tau","volume":"80","author":"Jacobs","year":"2019","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2022.105783_bb0125","doi-asserted-by":"crossref","first-page":"6861","DOI":"10.1021\/acs.jafc.7b02386","article-title":"Suppressive effect of ginsenoside Rg3 against lipopolysaccharide-induced depression-like behavior and neuroinflammation in mice","volume":"65","author":"Kang","year":"2017","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.nbd.2022.105783_bb0130","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.schres.2017.07.005","article-title":"Kynurenine pathway in schizophrenia: Galantamine-memantine combination for cognitive impairments","volume":"193","author":"Koola","year":"2018","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.nbd.2022.105783_bb0135","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/j.ajpath.2011.05.048","article-title":"The tryptophan metabolite 3-hydroxyanthranilic acid plays anti-inflammatory and neuroprotective roles during inflammation: role of hemeoxygenase-1","volume":"179","author":"Krause","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.nbd.2022.105783_bb0140","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.intimp.2013.08.018","article-title":"The tryptophan metabolite 3-hydroxyanthranilic acid suppresses T cell responses by inhibiting dendritic cell activation","volume":"17","author":"Lee","year":"2013","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.nbd.2022.105783_bb0145","doi-asserted-by":"crossref","first-page":"41473","DOI":"10.1038\/srep41473","article-title":"Kynurenine pathway metabolomics predicts and provides mechanistic insight into multiple sclerosis progression","volume":"7","author":"Lim","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.nbd.2022.105783_bb0150","doi-asserted-by":"crossref","first-page":"15056","DOI":"10.1038\/nrdp.2015.56","article-title":"Alzheimer\u2019s disease","volume":"1","author":"Masters","year":"2015","journal-title":"Nat. Rev. Dis. Primers."},{"key":"10.1016\/j.nbd.2022.105783_bb0155","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/jnc.13411","article-title":"The contribution of neuroinflammation to amyloid toxicity in Alzheimer\u2019s disease","volume":"136","author":"Minter","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2022.105783_bb0160","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1126\/science.281.5380.1191","article-title":"Prevention of allogeneic fetal rejection by tryptophan catabolism","volume":"281","author":"Munn","year":"1998","journal-title":"Science."},{"key":"10.1016\/j.nbd.2022.105783_bb0165","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/j.bbrc.2004.06.061","article-title":"3-Hydroxyanthranilic acid, one of metabolites of tryptophan via indoleamine 2,3-dioxygenase pathway, suppresses inducible nitric oxide synthase expression by enhancing heme oxygenase-1 expression","volume":"320","author":"Oh","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.nbd.2022.105783_bb0170","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1046\/j.1471-4159.1998.70010299.x","article-title":"3-Hydroxykynurenine, an endogenous oxidative stress generator, causes neuronal cell death with apoptotic features and region selectivity","volume":"70","author":"Okuda","year":"1998","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2022.105783_bb0175","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.pneurobio.2016.01.001","article-title":"Astrogliosis: an integral player in the pathogenesis of Alzheimer\u2019s disease","volume":"144","author":"Osborn","year":"2016","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.nbd.2022.105783_bb0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0006344","article-title":"The excitotoxin quinolinic acid induces tau phosphorylation in human neurons","volume":"4","author":"Rahman","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2022.105783_bb0185","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.neurobiolaging.2010.04.007","article-title":"Amyloid imaging results from the Australian imaging, biomarkers and lifestyle (AIBL) study of aging","volume":"31","author":"Rowe","year":"2010","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2022.105783_bb0190","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00406-012-0384-x","article-title":"Increased 3-hydroxykynurenine serum concentrations differentiate Alzheimer\u2019s disease patients from controls","volume":"263","author":"Schwarz","year":"2013","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.nbd.2022.105783_bb0195","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/j.1471-4159.2005.03070.x","article-title":"Tryptophan metabolism and oxidative stress in patients with Huntington\u2019s disease","volume":"93","author":"Stoy","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2022.105783_bb0200","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0165-5728(01)00496-9","article-title":"Occurrence of T cells in the brain of Alzheimer's disease and other neurological diseases","volume":"124","author":"Togo","year":"2002","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.nbd.2022.105783_bb0205","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s13195-019-0551-7","article-title":"Systemic and central nervous system metabolic alterations in Alzheimer's disease","volume":"11","author":"van der Velpen","year":"2019","journal-title":"Alz. Res. Ther."},{"key":"10.1016\/j.nbd.2022.105783_bb0210","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.imlet.2005.03.008","article-title":"Resveratrol suppresses interferon-gamma-induced biochemical pathways in human peripheral blood mononuclear cells in vitro","volume":"100","author":"Wirleitner","year":"2005","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.nbd.2022.105783_bb0215","article-title":"Expression of tryptophan 2,3-dioxygenase and production of kynurenine pathway metabolites in triple transgenic mice and human Alzheimer\u2019s disease brain","volume":"8","author":"Wu","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2022.105783_bb0220","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.intimp.2018.12.012","article-title":"Curcumin relieves depressive-like behaviors via inhibition of the NLRP3 inflammasome and kynurenine pathway in rats suffering from chronic unpredictable mild stress","volume":"67","author":"Zhang","year":"2019","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.nbd.2022.105783_bb0225","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.cell.2011.05.020","article-title":"Kynurenine 3-monooxygenase inhibition in blood ameliorates neurodegeneration","volume":"145","author":"Zwilling","year":"2011","journal-title":"Cell."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996122001759?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996122001759?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:32:00Z","timestamp":1760851920000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996122001759"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":45,"alternative-id":["S0969996122001759"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2022.105783","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systemic perturbations of the kynurenine pathway precede progression to dementia independently of amyloid-\u03b2","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2022.105783","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"105783"}}